ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
OCT findings as a biomarker of disease activity in retinopathy of prematurity.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the value of handheld spectral-domain OCT (SD-OCT) in detecting macular changes in retinopathy of prematurity (ROP) and their association with disease activity.
methodsThis cross-sectional study included 95 eyes of 59 infants diagnosed with treatment-requiring ROP. All eyes underwent indirect ophthalmoscopic examination and handheld SD-OCT imaging prior to treatment. Clinical staging, presence of plus disease, and prior therapies were recorded. OCT images were analyzed for cystoid macular edema (CME), retinoschisis, preretinal tissue, and subclinical retinal detachment. Associations between OCT findings and clinical parameters were evaluated.
resultsBased on indirect ophthalmoscopy, 34.7% of eyes were at stage 3, 34% stage 4 A, 12% stage 4B, 3% aggressive ROP, and 14% presented with persistent avascular retina. CME was detected in 6 eyes (6.3%), significantly associated with plus disease (67%, p = 0.04), but not with gestational age, birth weight, or ROP stage. Retinoschisis was identified in 7 eyes (7.3%), predominantly in stage 4 A cases (71.4%). Preretinal tissue (3.1%) was observed mainly in aggressive ROP eyes. OCT refined staging in one case, reclassifying stage 4 A as stage 4B due to macular involvement.
conclusionHandheld SD-OCT uncovers macular abnormalities invisible to ophthalmoscopy and can alter disease staging. The significant association of CME with plus disease highlights its potential as biomarkers of disease activity. Routine OCT integration could transform ROP evaluation by refining staging and guiding timely intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.